baber/WOPTO huggingface dataset:
Patent NZ-516802-A (NZ)
Title: Vaccine composition
Inventor: BERTHET FRANCOIS-XAVIER JACQUE
IPC: A61P31/04
Filed: 2000-07-31
Abstract: Disclosed is a genetically-engineered bleb preparation isolated from a modified Neisseria meningitidis strain characterized in that said preparation is obtained by employing the following process: a) a process of reducing immunodominant variable or non-protective antigens within the bleb preparation comprising the steps of determining the identity of such antigen, engineering a bacterial strain to produce less or none of said antigen, and making blebs from said strain, wherein one or more of said antigens are selected from a list consisting of: PorA, PiIC, ThpA, TbpB, LbpA, and LbpB; and, optionally employing one or more further processes selected from the group b) to i) which are disclosed in the specification. Further disclosed is the use of the bleb preparation in the manufacture of a medicament for immunising a human against a disease caused by Neisseria meningitides.
Patent NZ-518001-A (NZ)
Title: Tyrosine kinase inhibitors
Inventor: ARRINGTON KENNETH L
IPC: A61K31/506
Filed: 2000-10-16
Abstract: Compounds of formula (I) are described wherein Z is selected from (II), (III) and (IV); and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for use as tyrosine kinase inhibitors.
Patent NZ-519671-A (NZ)
Title: Use of HIV and SIV gag proteins or amino acid residues to mediate the packaging and delivery of proteins, peptides, virions and virus like particles into cells
Inventor: KAPPES JOHN C
IPC: C12N15/63
Filed: 2000-12-14
Abstract: A viral vector system is provided comprising at least a first nucleic acid segment encoding at least one fusion protein comprising a functional portion of a truncated Gag polypeptide fused in frame to a functional portion of reverse transcriptase and/or integrase. The first nucleic acid segment is capable of expression in a mammalian cell to viral nucleic acid sequences present in the cell, where the functional portion of Gag is further capable of providing for the incorporation of the reverse transcriptase and/or integrase into a translenti viral particle produced within the cell.
Patent NZ-520885-A (NZ)
Title: Cooking aid used for flavouring food products
Inventor: MAHE YANNICK
IPC: A23P30/25
Filed: 2001-03-12
Abstract: A cooking aid composed of an envelope based on fat, which is solid at room temperature, and a fluid or pasty flavouring filling, and a process for manufacturing the same is disclosed, wherein the envelope of the product melts rapidly upon contact with hot food or in a frying pan and possesses good mechanical resistance to handling at room temperature. The envelope comprises of the order of 40 to 100 % of fat and from 0 to 60 % of filling additives of the polysaccharide, protein or fibre type or a mixture thereof. The aqueous and/or fatty filling of the product according to the invention has a viscosity which is in the range between liquid honey and a pasty spread.
Patent NZ-525039-A (NZ)
Title: Activated sludge wastewater treatment system and method
Inventor: O LEARY KEVIN P
IPC: C02F3/00
Filed: 2001-09-06
Abstract: An improved activated sludge system and method for treating wastewater containing contaminants is disclosed which offers a broad array of advantages over conventional activated sludge wastewater treatment systems, including smaller size, higher rates of operation, higher oxygen transfer efficiency, lower operating costs, and a substantially decreased level of excess sludge production. The improved activated sludge waste treatment system of the present invention has two processing tanks rather than the several tanks that are commonly found in activated sludge systems for treatment and sludge treatment equalizations, including anaerobic processes. The first processing tank is a contact tank (42) which hosts a reaction which functions not merely to digest the maximum amount of contaminants, but instead to bind contaminants to the micro-organisms through absorption, adsorption, precipitation, or digestion so that they can then be removed from the liquid in a solid/liquid separator (50). The activated sludge removed by the solid/liquid separator (50) is then supplied to a digester tank (54) containing a high concentration of activated sludge, where virtually complete digestion is achieved to minimize the volume of solids remaining. Activated sludge is provided from the digester tank (54) to the contact tank (42) to facilitate the reaction in the contact tank.
Patent NZ-530337-A (NZ)
Title: Process fro making wood pulp from eucalyptus using the white rot fungus Ceriporiopsis subvermispora followed by mechanical pulping
Inventor: AKHTAR MASOOD
IPC: D21B1/16
Filed: 2002-05-30
Abstract: Disclosed is a method of making wood pulp from eucalyptus wood comprising inoculating eucalyptus wood chips in a bioreactor with an inoculum including a viable culture of the white rot fungus, Ceriporiopsis subvermispora. The chips are then incubated under condition for the propagation of the fungus through the wood chips for a time to allow the fungus to modify a significant amount of the lignin naturally present in the wood chips. The wood chips degraded by the fungus are then mechanically pulped into a paper pulp. The pulp can be used to produce paper having at least a 70% improvement in burst index and at least 184% improvement in tear index over paper produced by mechanical pulping of eucalyptus wood without C. subvermispora inoculation.
Patent NZ-535876-A (NZ)
Title: Method and computer for experimental design
Inventor: SCHUPPERT ANDREAS
IPC: G05B15/02
Filed: 2003-04-02
Abstract: A method for experimental design comprises: A) selection of at least one first experiment from an experiment range by a data-driven optimizer; B) input of data for the first experiment that has been determined by experimentation; C) use of a meta-layer for evaluating the experiment data; D) input of the experiment data determined by experimentation for the first experiment into the data-driven optimizer; E) influencing of the data-driven optimizer by the result of the evaluation; F) selection of at least one second experiment from the experiment range by the data-driven optimizer. The meta-layer contains a neuronal network and/or a hybrid model and/or a rigorous model and/or a data mining method.
Patent NZ-536330-A (NZ)
Title: Medical devices such as stents comprising haemocompatible coating, production and use thereof
Inventor: HORRES ROLAND
IPC: A61K31/436
Filed: 2003-04-15
Abstract: The disclosure relates to the use of polysaccharides containing the sugar structural element N-acylglucosamine for producing haemocompatible surfaces, in addition to methods for coating surfaces in a haemocompatible manner with said polysaccharides, the latter constituting the common biosynthetic precursor substances of heparin and heparan sulphates. The disclosure also relates to coated medical products, in particular stents, which contain paclitaxel as an antiproliferative active ingredient, in addition to the use of said stents for preventing restenosis.
Patent NZ-537456-A (NZ)
Title: Whey products and a process for preparing a modified whey protein concentrate
Inventor: HAVEA PALATASA
Filed: 2004-12-24
Abstract: The process for preparing a modified whey protein concentrate is disclosed, which comprises: (a) providing a whey protein solution having less than 5% total solids and a combined calcium and magnesium concentration of less than 70 mmol/kg on a dry basis and a pH of 6.0-7.5; (b) heat treating the solution obtained to greater than 70 Deg C for up to 60 minutes to denature the whey protein; (c) cooling the heated solution to 40-60 Deg C; and (d) spray drying to prepare a dried product. Also disclosed is a method for preparing a whey protein concentrate comprising: (a) providing a whey protein concentrate comprising of about 10-30% (w/w) total solids, a combined calcium and magnesium concentration of less than 70 mmol/kg, on a dry basis, and a pH of 6.5-7.5; (b) heating using a scraped surface heat exchanger (SSHE) to a temperature of greater than 70 Deg C for up to 60 minutes to denature the whey protein; (c) cooling the heated solution to 40-60 Deg C; and (d) spray drying to prepared a dried product.
Patent NZ-540324-A (NZ)
Title: A light collector
Inventor: FRANKLIN JAMES BRUCE
IPC: F21V8/00
Filed: 2003-11-05
Abstract: A light collector having a dye molecule concentration C is disclosed. The dye molecules are dispersed in a light transmissive medium. The concentration C is lower than a concentration C' and selected, so that in use, attenuation of light due to re-absorption or scattering in the main emission wavelength range of the dye molecules is lower than if the concentration would be C'. The concentration C is selected so that the combined emission and absorption efficiency of the light collector is higher than that for the concentration C'.
Patent NZ-542590-A (NZ)
Title: New galenic system for transport of an active constituent, preparation process and use
Inventor: IOUALALEN KARIM
IPC: A61P31/00
Filed: 2004-03-24
Abstract: Disclosed is a galenic system in the form of strictly hydrophobic solid lipid particles with a size of between 0.5 microns and 1500 microns, having a melting temperature between 15 deg C and 75 deg C containing no water, surfactants, emulsifying agents or traces of solvents, including at least one hydrophobic wax wherein the galenic system at least one non-neutralised fatty acid and at least one active constituent which is not present on the surface of the particles. Also disclosed is a process for the preparation of a galenic system in the form of strictly hydrophobic solid lipid particles including an active constituent, wherein: a) at least one hydrophobic wax and at least one non-neutralised fatty acid are mixed hot, while stirring, at 2 deg C or 3 deg C above the melting point of the compound with the highest melting point, and then the active constituent is added, b) lipid droplets including the active constituent are formed by dispersing the mix obtained in the first step in a gel with which the said mix is immiscible, previously adjusted to the same temperature as the mix obtained in the first step, and with a content of gelifying agent between 0.1 g/l and 30 g/l , c) immediately at the end of dispersion, the droplets are immediately cooled below the solidification temperature of the mix, then washed with water or with water containing ethanol, and, d) the washed particles having a size between 0.5 microns and 1500 microns are recovered by sieving and drying.
Patent NZ-546598-A (NZ)
Title: Process for alcohol production
Inventor: SCOTT MAX
IPC: C12H6/00
Filed: 2006-04-13
Abstract: Disclosed is a method of treating a wine product comprising material so as to reduce the amount of the material from the wine product to produce a treated wine product having substantially no colour, odour or flavour, the method comprising subjecting the wine product to the following in order from (a) to (f): a) at least one nanofiltration step to remove or reduce material having a size range of about 100 daltons to 1600 daltons; b) at least one ion exchange step to substantially remove or reduce dissolved or suspended material; c) optionally, at least one sterile filtration step; d) optionally, at least one fortification step with a high alcohol-concentration spirit to increase the alcohol concentration of the treated wine product to at least about 20%(v/v); e) at least one carbon filtration step; and f) optionally, at least one polish filtration step through a filter having a pore size of about 1.0 micrometer to about 1.5 micrometer. Also disclosed is an apparatus for treating a wine product wherein the apparatus is disclosed within the specification.
Patent NZ-549962-A (NZ)
Title: Substituted phenoxy-and phenylthio-derivatives for treating proliferative disorders
Inventor: REDDY E PREMKUMAR
IPC: C07C317/18
Filed: 2005-03-15
Abstract: Disclosed is a compound of formula I, or a salt thereof, wherein A is -S- or -O-, X is -CHRxSO2- or -NRxSO2-, Q is aryl or heteroaryl, and the other substituents are as described in the specification. Also disclosed are intermediates useful for the production of the above compounds, processes for preparing them, and conjugates of the compounds with antibodies. Also disclosed is the use of the compound for treating a proliferative disorder, such as cancer.
Patent NZ-551368-A (NZ)
Title: Can end
Inventor: TURNER TIMOTHY
IPC: B65D17/34
Filed: 2005-05-12
Abstract: An easy open can end member 10 comprising a center panel 18 positioned about a longitudinal axis perpendicular to a diameter of the center panel 18, the center panel 18 including a closure member for sealing the end member 10, a portion of the closure member being retainable to a portion of the center panel 18 once the easy open can end member 10 is opened, a curl 12 defining an outer perimeter of the end member 10, a circumferential chuck wall 14 extending downwardly from the curl 12, and a transition wall 16 connecting the chuck wall 14with a peripheral edge of the center panel 18, the transition wall 16 comprising a folded portion, the folded portion having a first leg, a second leg, and a third leg, the first leg connected to the chuck wall 14and joined to the second leg by a concave annular portion, the second leg joined to the third leg by a convex annular portion, and the third leg joined to the center panel 18, the convex annular portion having an inner radius of curvature joining the second leg with the third leg, wherein the inner radius of curvature is greater than O.05Imm.
Patent NZ-553566-A (NZ)
Title: Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
Inventor: HEIDELBAUGH TODD M
IPC: A61K31/4174
Filed: 2005-09-07
Abstract: Disclosed is the use of benzyl substituted 1,3-dihydro-imidazole-2-thione compounds of formula (I), where n is 1 or 2 and R1 is F, Cl, Br or I, for the manufacture of a medicament for the treatment of pain. The pain could be chronic pain, visceral pain, neuropathic pain or corneal pain. Also disclosed are compounds 1-5 as shown and a pharmaceutical composition of compounds 1-5.
Patent NZ-555719-A (NZ)
Title: Nanoparticle composition and methods for synthesis thereof
Inventor: PAYNE TREVOR
IPC: A61K9/51
Filed: 2005-12-30
Abstract: Disclosed is a method of producing a nanoparticle composition comprising nanoparticles of a therapeutically effective agent, comprising the step of: mechanochemical synthesis of a mixture of a precursor compound and a co-reactant using milling media in a milling apparatus, for a time period sufficient to produce the nanoparticle composition comprising nanoparticles of the therapeutically effective agent dispersed within a solid carrier matrix.
Patent NZ-556498-A (NZ)
Title: Aqueous solution of Sn(II) carboxylic acid complex for reducing chromium (VI) ions into chromium (III)
Inventor: ANDREANI PIERRE-ANTOINE
IPC: C07G99/00
Filed: 2006-04-13
Abstract: Disclosed is an additive when used to reduces Cr(VI) ions to Cr(III) ions, comprising an aqueous solution of a complex of tin(II), and a carboxylic acid such as gluconic acid or a salt thereof, wherein the additive has a pH over 2. Also disclosed is the use of the additive for preparing a material such as a cement, fly ash or slag with reduced chromium (VI) content; and a process for preparing the additive.
Patent NZ-560489-A (NZ)
Title: Animal monitoring system and apparatus thereof
Inventor: GIBSON DAVID JOHN MICHAEL
Filed: 2006-05-10
Abstract: A system for monitoring animals is disclosed. A data-logger unit (102) is attached to an animal and logs data regarding the animal and/or the animal's environment. Data from the data-logger is wirelessly transmitted to, and stored on, a data storage means (104). A website (105) provides access to the data that is stored.
Patent NZ-562140-A (NZ)
Title: Household appliances for washing and/or drying clothes
Inventor: BARI ELISABETTA
IPC: D06F58/16
Filed: 2006-03-13
Abstract: Household appliance for washing and/or drying clothes comprising an outer casing (2) provided with a worktop (3) and a front panel (4) carrying operational input controls (5), an opening for loading and unloading clothes, a door (6) for closing the opening, a rotational drum supported inside the casing (2). The worktop (3) comprises heating means to dry garments disposed on the worktop (3).
Patent NZ-565645-A (NZ)
Title: Cable barrier system
Inventor: NEUSCH WILLIAM H
IPC: E01F15/00
Filed: 2006-03-10
Abstract: A cable barrier system 10 for redirecting errant object like a motor vehicle towards a safer path. The cable barrier system a cable-release anchor assembly 17, a terminal end section 14 with at least one terminal post 20 placed next to the cable-release anchor assembly 17, a length of need section 16 with a number of line posts 24 spaced apart from each other and at least one cable having a terminal end. Each line post 24 has an internal cavity and a slot formed along a sidewall extending downwards from its top end. The cable is releasably held in tension by the cable-release anchor assembly 17 placed next to the terminal end. The cable is also releasably held by the terminal posts 20 and by the line posts 24. The cable's releasable connection to each of the line posts utilises a post-cable connector. The post-cable connector has an elongated portion forming sliding loops, with the elongated portion mainly inside the line post's 24 internal cavity and the loops extending through the slot in the line post 24. Thus the cable's connection to the line post 24 is such that when the line post 24 is struck by a moving object, like a motor vehicle, the cable will be released from the deformed line post 24 in a manner that allows the cable to stay in contact with the moving object.
Patent NZ-566000-A (NZ)
Title: Air quality sensor which causes a checklist to be generated on a display
Inventor: FAULKHEAD SHANE
IPC: G08B3/10
Filed: 2006-07-14
Abstract: Disclosed is an atmospheric safety monitoring device. The device includes a remote sensor unit located in an area (4) of a vessel (3), the sensor unit adapted to sense two or more selected atmospheric contaminants and to communicate data from the sensing to a display unit (1). The display unit displays the results of the sensing and determines if the results indicate that a level of an atmospheric contaminant is outside of an acceptable range, and in that case to initiate selected alert behaviour. The selected alert behaviour includes displaying steps of a checklist of responses associated with the detection of the contaminant in the area.
Patent NZ-566429-A (NZ)
Title: Synthesis of renin inhibitors involving a cycloaddition reaction
Inventor: MICKEL STUART JOHN
IPC: C07C237/22
Filed: 2006-09-26
Abstract: Disclosed is a process for the manufacture of a compound of the formula III or a salt thereof, compounds useful as renin inhibitors, said manufacture comprising reacting a compound of formula I with a glycine compound of formula II in order to give the imine functionality, and wherein the substituents are as defined in the specification.
Patent NZ-575066-A (NZ)
Title: Hybrid foam proportioning system
Inventor: LASKARIS MICHAEL A
IPC: A62C5/027
Filed: 2009-02-23
Abstract: A hybrid foam system for providing a variety of proportioned foam solutions is provided. The system includes a low flow foam proportioning system operatively associated with a high flow foam proportioning system and a system controller for controlling the operating conditions of the overall hybrid foam system.
Patent NZ-577769-A (NZ)
Title: 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands
Inventor: RAMAKRISHNA NIROGI VENKATA SATYA
IPC: A61K31/404
Filed: 2007-07-26
Abstract: Disclosed are indole compounds substituted at the N position by arylsulphonyl and at the 5 position by a piperazine derivative. The compounds are represented by formula (I) where the variables are as described in the disclosure. The compounds can be used to regulate the 5-HT6 receptor. Also disclosed is the process to make compounds of formula (I); pharmaceutical compositions comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for the treatment of anxiety, Alzheimer's disease, depression, obsessive-compulsive disorders, cognitive memory disorders, Parkinson's disease, schizophrenia, panic disorders, withdrawal from drug abuse syndrome, stroke, head trauma, neurodegenitive disorders gastrointestinal and/or obesity.
Patent NZ-586449-A (NZ)
Title: Apparatus and method for internally lining an elongate member
Inventor: BOURNE REGINALD CHARLES
IPC: B29C63/26
Filed: 2009-02-05
Abstract: An apparatus 10 for internally lining a pipe 11 comprises an outer barrel portion 20 and an inner mould head 19 with an annular mould cavity defined between them, and means 12 for providing a settable material 18 to the mould cavity. The settable material 18 is injected into the mould cavity as the pipe 11 is forced past the cavity, thus providing an internal lining for the pipe 11.
Patent NZ-596556-A (NZ)
Title: Melanocortin receptor-specific peptides
Inventor: DODD JOHN H
IPC: A61P3/04
Filed: 2010-06-07
Abstract: 596556 The disclosure relates to melanocortin receptor-specific (MC4-R specific) cyclic peptides of Formula (I) or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4a, R4b, R4C, R5, x and y are as defined in the specification. These compounds are particularly useful in the treatments of energy homeostasis and metabolism related (e.g. diabetes), food intake related and/or energy balance and body weight related diseases, disorders and/or conditions, including obesity, overweight and diseases, disorders and/or conditions associated with obesity and/or overweight, such as type 2 diabetes and metabolic syndrome. Compounds of the disclosure include: Ac-Arg-cyclo(Glu-Asn-D-Phe(4-CN)-Arg-Trp-Orn)-NH2 (SEQ ID NO:48); Ac-Arg-cyclo(Glu-Gln-D-Phe(4-CN)-Arg-Trp-Orn)-NH2 (SEQ ID NO:51); Ac-Arg-cyclo(Glu-Asn-D-Phe(4-F)-Arg-Trp-Orn)-NH2 (SEQ ID NO:74); Ac-Arg-cyclo(Glu-Asn-D-Phe(4-CN)-Arg-Trp-Orn)-OH (SEQ ID NO:90); Ac-Arg-cyclo(Glu-Gln-D-Phe(4-CN)-Arg-Trp-Orn)-OH (SEQ ID NO:91); Ac-Arg-cyclo(Glu-Gln-D-Phe(4-F)-Arg-Trp-Orn)-NH2 (SEQ ID NO:97); Ac-Arg-cyclo(Glu-Pro-D-Phe(4-CN)-Arg-Trp-Orn)-NH2 (SEQ ID NO:44); Ac-Arg-cyclo(Glu-Pro-D-Phe(4-F)-Arg-Trp-Orn)-NH2 (SEQ ID NO:72); and Ac-Arg-cyclo(Glu-Pro-D-Phe(4-F)-Arg-Trp-Orn)-OH (SEQ ID NO: 107).
Patent NZ-600390-A (NZ)
Title: Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
Inventor: TANIS STEVEN P
IPC: A61K31/426
Filed: 2010-12-15
Abstract: ABSTRACT - 600390 The disclosure relates to relates to a sodium salt and a potassium salt of thiazolidinedione derivative compounds represented by structural formula (A) and (B) that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease).
Patent NZ-618916-A (NZ)
Title: Constitutively active aba receptor mutants
Inventor: CUTLER SEAN R
IPC: C12N15/82
Filed: 2012-06-19
Abstract: Discloses an isolated nucleic acid comprising a polynucleotide encoding a mutated Pyrabactin resistance 1/PYR1-like (PYR/PYL) receptor polypeptide comprising one or more amino acid substitutions in a ligand-binding pocket and/or a type 2 protein phosphatase (PP2C) binding interface as compared to a wild-type PYR/PYL receptor polypeptide, wherein the mutated PYR/PYL receptor polypeptide comprises a mutation, relative to the wild-type PYR/PYL receptor polypeptide, at a position corresponding to position V83 in PYR1 as set forth in SEQ ID NO:1, and wherein the mutated PYR/PYL receptor binds to PP2C in the absence of abscisic acid; wherein the sequence is as defined in the complete specification. Also discloses expression cassettes containing the same and methods of producing a plant having inhibited PP2C activity.